CORONARY ARTERY SURGERY: Edited by Marc RuelHybrid coronary revascularization: are we there yet?McKiernan, Maureen; Halkos, Michael E.Author Information Department of Surgery, Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Georgia, USA Correspondence to Michael E. Halkos, Department of Surgery, Division of Cardiothoracic Surgery, Emory University School of Medicine, 1365 Clifton Rd., Suite A2202, Atlanta, GA 30322, USA. Tel: +1 404 686 2513; e-mail: [email protected] Current Opinion in Cardiology: November 2020 - Volume 35 - Issue 6 - p 673-678 doi: 10.1097/HCO.0000000000000784 Buy Metrics Abstract Purpose of review With advances in minimally invasive surgical and percutaneous coronary therapies, hybrid coronary revascularization (HCR) is well positioned to be an ideal strategy for revascularization in selected patients with multivessel coronary artery disease (CAD). The purpose of this review is to highlight recent outcomes and comparative effectiveness studies of HCR. Recent findings Patients undergoing HCR have comparable outcomes compared with coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI). The major benefits compared with CABG appear to be related to short-term morbidity and resource utilization. Compared with PCI, HCR may decrease repeat revascularization rates by decreasing reintervention of the left anterior descending coronary artery. Summary Although HCR is associated with a significant learning curve, specifically with minimally invasive CABG techniques, the early outcomes remain promising and should be considered as a viable option for revascularization in select patients with multivessel CAD. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.